Physician profile
James Reinersman
NPI 1568698108
$39,844.01
in general payments reported to CMS, 2019-2025
21 companies · $19K in 2025
The $19K reported for 2025 was more than what 93% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,297 · 2020: $411 · 2021: $2,826 · 2022: $1,921 · 2023: $8,307 · 2024: $6,508 · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $13K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,900 · Travel and Lodging: $7,916 · Food and Beverage: $3,073.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $12,500.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,900.00 |
| Travel and Lodging | $7,916.16 |
| Food and Beverage | $3,072.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $36,680.39 | 2019-2025 | Da Vinci Sp, Da Vinci Surgical System |
| Atricure, INC. | $956.25 | 2019-2025 | Atricure Cryoice Cryoablation System (Cryo2), Atricure Cryoice Cryosphere Cryoablation System |
| Zimmer Biomet Holdings, INC. | $621.42 | 2020-2021 | |
| Medtronic, INC. | $454.18 | 2021-2023 | Illumisite |
| Veran Medical Technologies, INC. | $378.25 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $216.95 | 2022-2025 | |
| Ethicon US, LLC | $106.25 | 2019 | |
| Stryker Corporation | $86.37 | 2021 | |
| Merck Sharp & Dohme LLC | $49.73 | 2023-2025 | Keytruda |
| Lilly USA, LLC | $46.19 | 2023 | Retevmo |
| Fujifilm Healthcare Americas Corporation | $35.22 | 2024 | Fujifilm |
| Depuy Synthes Sales INC. | $32.22 | 2025 | |
| Daiichi Sankyo INC. | $27.49 | 2025 | Enhertu |
| Genentech USA, INC. | $27.38 | 2023 | Tecentriq |
| Acera Surgical, INC. | $25.57 | 2025 | Restrata Wound Matrix |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Octapharma USA, INC. | $18.84 | 2025 | Fibryga |
| E.R. Squibb & Sons, L.L.C. | $17.86 | 2023 | Opdivo |
| Recordati_rare_diseases_inc. | $16.74 | 2022 | |
| Eusa Pharma (US) LLC | $16.74 | 2022 | |
| Kls-Martin L.P. | $15.30 | 2023 | |
| Pulmonx Corporation | $14.67 | 2025 | Zephyr Endobronchial Valve, Zephyr Delivery Catheter, Chartis Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Reinersman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.